Eligibility Policies for the State AIDS Drug Assistance Programs

References

• Baily , M. , Bilheimer , L. Woolridge , J. 1990 . “Economic Consequences for Medicaid of Human Immunodeficiency Virus Infection.” . Health Care Financing Review , : 97 – 108 . 1990 Annual Supplement
   PubMedGoogle Scholar
• Bassetti , S. , Battegay , M. , Furrer , H. , Rickenbach , M. , Flepp , M. , Kaiser , L. Telenti , A. 1999 . “Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.” . Journal of Acquired Immune Deficiency Syndromes , 21 ( 2 ) : 114 – 9 .
   PubMed Web of Science ®Google Scholar
• Bozzette , S. , Berry , S. , Duan , N. , Frankel , M. Leibowitz , A. 1998 . “The Care of HIV-Infected Adults in the United States.” . The New England Journal of Medicine , 338 ( 26 ) : 1897 – 1904 .
   Google Scholar
• Buchanan , R. 1997a . “The Ryan White CARE Act: The Allocation of Title II Funding Among Programs by the States.” . AIDS & Public Policy Journal , 12 ( 3 ) : 105 – 111 .
   PubMedGoogle Scholar
• Buchanan , R. 1997b . “Health Insurance Continuation Programs Funded by Title II of the Ryan White CARE Act.” . AIDS & Public Policy Journal , 12 ( 2 ) : 57 – 65 .
   PubMedGoogle Scholar
• Buchanan , R. 1997c . “Home and Community-Based Care Funded by Title II of the Ryan White CARE Act.” . AIDS & Public Policy Journal , 12 ( 1 ) : 3 – 20 .
   PubMedGoogle Scholar
• Buchanan , R. 1996a . “HIV Consortia Services Funded by Title II of the Ryan White CARE Act: A Survey of the States.” . AIDS & Public Policy Journal , 11 ( 3 ) : 118 – 143 .
   PubMedGoogle Scholar
• Buchanan , R. 1996b . “Medicaid Eligibility Policies for People with AIDS.” . Social Work in Health Care , 23 ( 2 ) : 15 – 41 .
   PubMed Web of Science ®Google Scholar
• Buchanan , R. and Chakravorty , B. 1999 . “Assessments of the Coverage of HIV-Re-lated Care by Public Programs: A Survey of AIDS Service Organizations.” . Social Work in Health Care , 29 ( 3 ) : 19 – 42 .
   PubMed Web of Science ®Google Scholar
• Buchanan , R. and Smith , S. 1998 . “State Implementation of the AIDS Drug Assistance Programs.” . Health Care Financing Review , 19 ( 3 ) : 39 – 62 .
   PubMed Web of Science ®Google Scholar
• Buchanan , R. and Smith , S. 1996 . “Drug Assistance Programs Funded by Title II of the Ryan White CARE Act: A Survey of the States,” . AIDS & Public Policy Journal , 11 ( 4 ) : 185 – 203 .
   PubMedGoogle Scholar
• Buchanan , R. and Smith , S. 1994 . “Medicaid Policies for HIV-Related Prescription Drugs.” . Health Care Financing Review , 15 ( 3 ) : 43 – 61 .
   PubMedGoogle Scholar
• Carpenter , C. , Cooper , D. , Fischl , M. , Gatell , J. Gazzard , B. 2000 . “Antiretro-viral Therapy in Adults.” . Journal of the American Medical Association , 283 ( 3 ) : 381 – 390 .
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . 1999 . USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: U. S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA) MOIRE 1999;48(No. RR-10)
   Google Scholar
• Christenson , D. B. 1978 . “Drug-taking compliance: A review and synthesis.” . Health Services Research , 6 : 171 – 187 .
   Google Scholar
• d'Arminio Monforte , A. , Testa , L. , Adorni , F. , Chiesa , E. , Bini , T. , Moscatelli , G. C. Abeli , C. 1998 . “Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.” . AIDS , 12 ( 13 ) : 1631 – 7 .
   PubMed Web of Science ®Google Scholar
• Davis , S. , Canniff , J. , Andradas , V. , Cohen , C. and Helinger , J. “Successful Titonavir Induction: Intensive Patient Management.” . 4th Conf. Retro. and Opportunistic Infection . January 22–26 1997 . pp. 100
   Google Scholar
• Ferrando , S. , Wall , T. , Bakti , S. and Sorensen , J. 1996 . “Psychiatric Morbidity, Illicit Drug Use, and Adherence to Zidovudine (AZT) Among Injection Drug Users with HIV.” . American Journal Drug Alcohol Abuse , 22 ( 4 ) : 475 – 487 .
   PubMed Web of Science ®Google Scholar
• Health Resources and Services Administration . 1999a . HIV/AIDS Services, Ryan White CARE Act September 17, 1999, http://www.hrsa.gov/hab/A/4web/act.htm
   Google Scholar
• Health Resources and Services Administration . 1999b . HIV/AIDS Services, Fact Sheet: Title II Ryan White CARE Act September 17, 1999, http://www.hrsa.gov/hab/B/factsheets/title2–1.htm
   Google Scholar
• Health Resources and Services Administration . 1999c . HIV/AIDS Services, Fact Sheet: The Ryan White CARE Act AIDS Drug Assistance Programs (ADAPs) September 17, 1999, http://www.hrsa.gov/hab/B/factsheets/ADAP1.htm
   Google Scholar
• Kovacs , J. A. 1999 . “Immune-based therapies in the management of HIV-infected patients.” . In AIDS Therapy , Edited by: Dolin , R. , Masur , H. and Saag , M. S. Philadelphia : Churchill Livingstone . 1999
   Google Scholar
• Ledergerber , B. , Egger , M. , Erard , V. , Weber , R. Hirschel , B. 1999 . “AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral Therapy.” . Journal of the American Medical Association , 282 ( 23 ) : 2220 – 2226 .
   PubMed Web of Science ®Google Scholar
• Lucas , G. M. , Chaisson , R. E. and Moore , R. D. 1999 . “Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions.” . Annals of Internal Medicine , 131 ( 2 ) : 81 – 87 .
   PubMed Web of Science ®Google Scholar
• Moore and Chaisson . 1996 . “Natural History of Opportunistic Disease in an HIV-in-fected Urban Clinical Cohort.” . Annals of Internal Medicine , 124 : 633 – 642 .
   PubMed Web of Science ®Google Scholar
• Nannis , E. and Temoshok , L. 1993 . “Perceptions of AZT: Implications for Adherence to Medical Regimens.” . Journal of Applied Biobehavioral Research , 1 ( 1 ) : 39 – 54 .
   Google Scholar
• Palella , F. J. , Delaney , K. M. , Moorman , A. C. , Loveless , M. O. Fuhrer , J. 1998 . “Declining Morbidity and Mortality Among Patients with Advanced Human Immunodeficiency Virus Infection.” . The New England Journal of Medicine , 338 ( 13 ) : 853 – 860 .
   PubMed Web of Science ®Google Scholar
• Shapiro , M. , Morton , S. McCaffrey , D. 1999 . “Variations in the Care of HIV-Infected Adults in the United States.” . The Journal of the American Medical Association , 281 : 2305 – 2315 .
   PubMed Web of Science ®Google Scholar
• Singh , N. 1996 . “Determinants of Compliance with Antiretroviral Therapy in Patients with Human Immunodeficiency Virus: Prospective Assessment with Implications for Enhancing Compliance.” . AIDS Care , 8 ( 3 ) : 261 – 269 .
   PubMed Web of Science ®Google Scholar
• Sparano , J. A. , Anand , K. , Desai , J. , Mitnick , R. J. , Kalkut , G. E. and Hanau , L. H. 1999 . “Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center.” . Journal of Acquired Immune Deficiency Syndromes , 21 ( Suppl 1 ) : S18 – 22 .
   Google Scholar
• Steinbrook , R. 1998 . “Caring for People with Human Immunodeficiency Virus Infection.” . The New England Journal of Medicine , 339 ( 26 ) : 1926 – 1928 .
   PubMed Web of Science ®Google Scholar
• U. S. General Accounting Office . 1998 . “HIV/AIDS Drugs, Funding Implications of New Combination Therapies for Federal and State Programs.” GAO/HEHS-99–2, October 14, 1998
   Google Scholar
• Walsh , J. C. , Jones , C. D. , Barnes , E. A. , Gazzard , B. G. and Mitchell , S. M. 1998 . “Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors.” . AIDS , 12 ( 6 ) : 613 – 618 .
   PubMed Web of Science ®Google Scholar